
Apremilast (30mg)
Active composition
Apremilast inhibits phosphodiesterase 4, leading to increased levels of cyclic AMP, which subsequently reduces the production of pro-inflammatory cytokines.
Medical applications
Mprila Tablet, containing 30mg of Apremilast, is a prescription pharmaceutical designed for the treatment of adult patients with moderate to severe plaque psoriasis, active psoriatic arthritis, and oral ulcerative colitis. Its primary mechanism of action involves inhibition of phosphodiesterase 4 (PDE4), thereby reducing inflammation associated with these conditions. The Mprila Tablet should be administered orally twice daily, with or without food, and should not be crushed, chewed, or dissolved in liquid. Regular monitoring of blood lipids and weight is recommended during treatment, as well as close observation for potential side effects such as diarrhea, nausea, and headache. As with any medication, individual responses may vary, and it is crucial to consult a healthcare professional for personalized advice and dosage adjustments.
How to use Mprila Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Mprila Tablet may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Caution is advised when consuming alcohol with Mprila Tablet. Please consult your doctor.
High Risk
Mprila Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
It is not known whether Mprila Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Exercise Caution
Mprila Tablet is safe to use in patients with liver disease. No dose adjustment of Mprila Tablet is recommended.
Regular Checkup
Information regarding the use of Mprila Tablet during breastfeeding is not available. Please consult your doctor.
Consult Doctor
Mprila Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Mprila Tablet may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Mprila Tablet

Apremilast (30mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Apremilast inhibits phosphodiesterase 4, leading to increased levels of cyclic AMP, which subsequently reduces the production of pro-inflammatory cytokines.
Medical applications
Mprila Tablet, containing 30mg of Apremilast, is a prescription pharmaceutical designed for the treatment of adult patients with moderate to severe plaque psoriasis, active psoriatic arthritis, and oral ulcerative colitis. Its primary mechanism of action involves inhibition of phosphodiesterase 4 (PDE4), thereby reducing inflammation associated with these conditions. The Mprila Tablet should be administered orally twice daily, with or without food, and should not be crushed, chewed, or dissolved in liquid. Regular monitoring of blood lipids and weight is recommended during treatment, as well as close observation for potential side effects such as diarrhea, nausea, and headache. As with any medication, individual responses may vary, and it is crucial to consult a healthcare professional for personalized advice and dosage adjustments.
How to use Mprila Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Mprila Tablet may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Caution is advised when consuming alcohol with Mprila Tablet. Please consult your doctor.
High Risk
Mprila Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
It is not known whether Mprila Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Exercise Caution
Mprila Tablet is safe to use in patients with liver disease. No dose adjustment of Mprila Tablet is recommended.
Regular Checkup
Information regarding the use of Mprila Tablet during breastfeeding is not available. Please consult your doctor.
Consult Doctor
Mprila Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Mprila Tablet may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Mprila Tablet















